Variability in vancomycin use in newborn intensive care units determined from data in an electronic medical record.
Data from an electronic medical record were used to demonstrate a large variation in the proportion of patients treated with vancomycin in 56 newborn intensive care units, which ranged from 18% to 70% . Use of oxacillin or nafcillin instead of vancomycin was rare during the first few years of the study period but was routine in 13% of the newborn intensive care units during the last few years of the study period. The use of electronic medical record data for studies of antibiotic use is discussed here.
Arnold
Cody
C
Department of Neonatology, Baylor University Medical Center, 3500 Gaston Ave., 3 Hoblitzelle, Dallas, TX 75246, USA. CodyA@BaylorHealth.edu
Clark
Reese
R
Bosco
Jaclyn
J
Shoemaker
Craig
C
Spitzer
Alan R
AR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000209:etiology; D019102:Infant, Very Low Birth Weight; D007363:Intensive Care Units, Neonatal / Q000706:statistics & numerical data*; D008297:Male; D016347:Medical Records Systems, Computerized / Q000706:statistics & numerical data*; D009254:Nafcillin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D009254:Nafcillin; D014640:Vancomycin; D010068:Oxacillin